Support for Cancer Clinical Trials Program

Overview

Important advances in cancer prevention, treatment and care can be made through clinical trials and people diagnosed with cancer will benefit from the outcomes of cancer clinical trials through improved evidence-based, best-practice care. Industry-independent cancer clinical trials can play an important role in the cancer research landscape because these trials can address important questions in patient treatment and care which may not be of commercial interest to the pharmaceutical industry. The primary aim of the Support for Cancer Clinical Trials program is to support Multi-site Collaborative Cancer Clinical Trials Groups to develop industry-independent cancer clinical trial protocols to the stage of application for grant funding.   The broader program objectives are to:  Increase the number of cancer clinical trials conducted in Australia Increase the participation in clinical trials by people affected by cancer  Increase the number of clinical sites actively participating in cancer clinical trials Increase the involvement of policy makers, clinicians, researchers and consumers in the development of cancer clinical trials  Increase National Cancer Cooperative Trials Group participation in national multi-group or international cancer clinical trials in Australia The outcome of this program is to guide scientific improvements in cancer prevention, treatment and care and in doing so build the evidence-base for best practice cancer care to improve health outcomes for Australian’s affected by cancer.